We report a near-full-length genome sequence of a foot-and-mouth disease virus (FMDV) of serotype Southern African Territories 2 (SAT 2), topotype VII, isolated from cattle during an FMDV outbreak in Bauchi State, Nigeria, in October 2014. This provides the first SAT 2 near-full-length genome sequence from West Africa and contributes to our understanding of viral spread and evolution.
F oot-and-mouth disease virus (FMDV; family Picornaviridae, genus Aphthovirus), the etiologic agent of foot-and-mouth disease, is one of the most economically impactful infectious diseases of livestock. Acutely infected animals develop characteristic vesicular lesions on the feet, tongue, snout, and teats (1, 2) . The seven distinct FMDV serotypes (A, Asia 1, C, O, and Southern African Territories [SAT] 1 to -3) are each defined based on VP1 coding sequences (3). SAT 2 was first identified in West Africa in 1974 (4) and is subdivided into 14 topotypes (https://www.wrlfmd.org/fmdv-genome/ fmd-prototype-strains#panel-8976). Topotype VII was first identified in Nigeria in 2007 (SAT2/NIG/2/07) (5). Transboundary livestock movement in West Africa contributes to FMDV spread (6) , and knowledge of the endemicity of FMDV genotypes is essential to understanding its molecular epidemiology. These considerations are important components of the Progressive Control Pathway for FMDV (PCP-FMDV) in Nigeria (7) .
The FMDV genome reported herein was isolated from cattle epithelium during an FMDV outbreak in Magama, Bauchi, Nigeria, in October 2014. The sample tested positive for FMDV by virus isolation on LFBK-␣ v ␤ 6 cells and was confirmed with FMDV-specific reverse transcriptase quantitative PCR (qRT-PCR) using the primers 5=-GACAAAGGTTTTGTTCTTGGTCA and 5=-TGCGAGTCCTGCCACGGA (8) . The total cell supernatant RNA was sequenced as previously described (9, 10) . In brief, the virus was passaged once in LFBK-␣ v ␤ 6 cells, and RNA was extracted from the supernatant using the MagMAX total RNA isolation kit, with the host DNA depleted using the DNA-free DNase kit (Ambion). The treated RNA underwent first-strand synthesis using a SuperScript first-strand synthesis system (Invitrogen) with random hexameric primers, a poly(T) primer targeting the 3= untranslated region (UTR), and one FMDV-specific primer targeting a conserved sequence in coding region 2A. Double-stranded cDNA was generated using a NEBNext Ultra II nondirectional RNA second-strand synthesis module (New England BioLabs) and purified with SPRIselect beads (Beckman Coulter). The sequencing library was constructed using the Nextera XT kit (Illumina) and sequenced on the NextSeq 500 platform. Reads were trimmed and filtered for quality and specific primers. In CLC Genomics Workbench 11.0, consensus sequences were compiled by both de novo assembly and read mapping to the full-length reference genome SAT 2 EGY/9/2012 (GenBank accession number JX014255), with a total of 11,916 reads covering 8,091 nucleotides (nt) in the final assembly and an average depth of 207.1 reads per site. This 8,091-nt near-full-length genome includes 999 nt of the 5= UTR, followed by the 7,008-nt polyprotein coding sequence and 84 nt of the 3= UTR (GC content, 54.4%). Phylogenetic analysis of the VP1 coding sequence identified it as serotype SAT 2, topotype VII, most closely related to viruses detected in Cameroon 3 months following (GenBank accession number MG873224), sharing 99.1% pairwise nucleotide identity (D. O. Ehizibolo and J. Arzt, unpublished data). A BLASTn query of the entire sequence did not identify any sequence with an identity above 80%. This discrepancy is the result of the very limited number of publicly available full-length FMDV genomes.
Given the ongoing efforts to control and eradicate FMDV in West Africa, there is a critical need for contemporary FMDV sequences. The genome sequence detailed in this announcement, SAT2/NIG/1/14, contributes to an understanding of the molecular epidemiology of FMDV in West Africa as part of the pathway to regional control.
Data availability. The assembled sequencing reads of SAT2/NIG/1/14 have been deposited in the NCBI under BioProject accession number PRJNA549649 and the consensus sequence under GenBank accession number MN103523.
